Multiple medications and treatments can be used to address dry eye and dry eye disease in patients, says Karen Fernandez, MD.

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

Treatment works, but treating one cow – let alone several – takes time. Extension specialists explain what a good management ...

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

Prior to the Uveitis (Sycamore) Study, there were few evidence-based therapies for children with moderate to severe uveitis, leading to many suffering serious visual complications and often blindness.

Sanofi SNY has announced that the FDA has granted a fast-track designation to its one-time intravitreal gene therapy, SAR446597, for the treatment of geographic atrophy (GA) due to age-related macular ...

Researchers created the latest artificial intelligence -centric retina tracker that can assist doctors in screening for a ...

A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be ...

Taking care of your heart has an influence on the health of your whole body. Here are the changes you should focus on, ...

Veligrotug demonstrated significant improvements in proptosis, diplopia, and clinical activity score among patients with active thyroid eye disease.